AGILE is designed as an open resource. Our Master Protocol, and associated templates for candidate-specific trial arms are published, and freely available for use by other researchers (at their own risk)...
The AGILE clinical trial platform is a new type of study designed for pandemic drug testing which represents a world-first for infectious diseases - capable of testing multiple potential treatments in parallel and speeding up testing by pooling control data across patient groups